Liquidia Corp. (LQDA)
64.01
+0.11
(+0.17%)
USD |
NASDAQ |
Jun 09, 16:00
64.47
+0.46
(+0.72%)
After-Hours: 20:00
Liquidia SG&A Expense (Quarterly) : 46.94M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 124.00M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Viatris, Inc. | 928.80M |
| ADMA Biologics, Inc. | 27.80M |